A Multicenter, Post Marketing Clinical Follow up (PMCF) Investigation to Evaluate the Performance and Safety of a Soft Silicone Foam Dressing and to Evaluate the Performance of Standard Care in Exuding Venous Leg Ulcers
1 other identifier
interventional
30
1 country
3
Brief Summary
This investigation is a Post Marketing Follow-Up Study for Mepilex XT conducted as part of Mölnlycke Health Care's quality system. The primary objective is to evaluate the performance of the dressing when used as intended on exuding Venous Leg Ulcers (VLUs) in the inflammatory and granulating stages of the wound healing process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2014
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 15, 2014
CompletedFirst Posted
Study publicly available on registry
June 19, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedResults Posted
Study results publicly available
October 26, 2016
CompletedOctober 26, 2016
May 1, 2014
1.2 years
May 15, 2014
October 13, 2015
September 6, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Changes From Baseline in Condition of the Peri Wound Skin
Deteriorationin of skin condition , Mepilex XT and Standard care (%)
16 weeks
Secondary Outcomes (3)
Pain Scores on the Visual Analog Scale
16 weeks
Users Feedback After Handling or Use as a Measure of Performance.
16 weeks
Measure of Actual Dressing Cost and Cost of Care, as Input for Health Economics Calculations.
16 weeks
Study Arms (2)
Standard care
ACTIVE COMPARATORstandard care ( such as alginate, hydrofiber or other treatment)
Intervention ( Mepilex XT)
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Venous Leg Ulcer
- Exuding wound
- Wound surface covered with sloughy tissue\* (before debridement)
- Wound size ≥ 6 cm2
- In case of multiple wounds, target wound must be ≥ 3cm distant from other wounds.
- Wound suitable for treatment with the relevant primary dressing\*\*
- Male or female, 18 years of age and above
- Signed Informed Consent
- Sloughy tissue defined as wet, yellow-brown fibrinous tissue present in the wound bed \*\* Mepilex XT in the intervention group. Standard care in the observation group
You may not qualify if:
- More than two products of 15 cm x15 cm needed to cover the whole wound and affected peri-wound area
- Wound cavity and/or fistula
- Full thickness burns
- Exposed tendons and/or fascia
- Bleeding wounds
- Malignant or fungating wounds
- Wound age \> 12 months
- Subject not suitable for the investigation according to the investigator's judgement
- Subject included in other ongoing clinical investigation which could interfere with this investigation, as judged by the investigator
- Known allergy/hypersensitivity to any of the components of the primary dressing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Nemocnice Podlesí a.s.
Třinec, Konská 453, 739 61, Czechia
Nemocnice Jihlava
Jihlava, Vrchlického, 586 01, Czechia
The General University Hospital in Prague
Prague, Czechia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- MuDr Jan Stryja
- Organization
- Nemocnice Podlesí
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2014
First Posted
June 19, 2014
Study Start
May 1, 2014
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
October 26, 2016
Results First Posted
October 26, 2016
Record last verified: 2014-05